Docket Number:11A-1020913
Inventor: Shui-Tein Chen, Ting-Fang Lo, Wei-Chung Tsai
IP Status:TW patent pending
Abstract:
Hepatocellular carcinoma is the 3rd leading cause of cancer death. In this invention, we found a specific microRNA, which could be induced by herbal medicine, can reduce hepatoma growth and induce apoptosis. This microRNA inhibits hepatoma via directly regulating catalytic isoforms and regulatory subunit of a specific enzyme family, which has a switch in gene expression from normal hepatocytes to hepatoma. Moreover, this microRNA inhibits a specific kinase which has been reported as a valid target for anti-cancer treatment. Our results demonstrate that this microRNA functions as a tumor suppressor, indicating its therapeutic potential in HCC.
Fields of Application:
Because this microRNA can suppress hepatoma via regulating the specific enzyme family and the specific kinase, the field of application for this invention is broad as below.
- Hepatocellular carcinoma
- Liver fibrosis and cirrhosis (The members of specific enzyme family play an important role in liver fibrosis and cirrhosis.)
- Glioblastoma, glioma, breast cancer (The specific kinase, increasing in many cancers, allows tumor growth and resists cell death.)
Advantages when compared to the existing technologies:
Overexpression of this microRNA increases the product concentration of the specific enzyme family. The product can selectively induce apoptosis in hepatoma cells, but not in normal hepatocytes.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
